Apogee Therapeutics, Inc. APGE Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Apogee Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s earnings yield?
- Apogee Therapeutics, Inc. (APGE) reported earnings yield of -4.4% in Q1 2026.
- How has Apogee Therapeutics, Inc.'s earnings yield changed year-over-year?
- Apogee Therapeutics, Inc.'s earnings yield increased by 53.8% year-over-year, from -9.5% to -4.4%.
- What is the long-term trend for Apogee Therapeutics, Inc.'s earnings yield?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s earnings yield has grown at a -11.0% compound annual growth rate (CAGR), from -6.3% to -5%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.